[url=]
NQ1!
NQ1! NAS100 NASDAQ 2023 APR 17 WEEK
12950 was supporting the market well despite increase
in distribution effort. Market participation was low though, and
shortening of thrust from high to high observed = waning
upward momentum.
Possible scenarios:
1) Market stuck in a 250pt range, wait till supply/demand is
resolved
Then:
2) Breakout of upper boundary to test 13740
= long at support of upper boundary of range
3) Breakdown of lower boundary of range
= Short on rejection of 12950
Volume Analysis:
Weekly = Ave vol narrow spread up bar close off high
= Minor weakness
Daily: Higher vol narrow spread down bar close away from low
= minor demand
Price reaction levels:
Short on Test and Reject | Long on Test and Accept
14361 13740 13550 - 137440
12950 10710 - 11068
Remember to Like and Follow if you find this useful.
Have a profitable trading week ahead.
NQ1! NQ1! NAS100 NASDAQ 2023 APR 17 WEEK
12950 was supporting the market well despite increase
in distribution effort. Market participation was low though, and
shortening of thrust from high to high observed = waning
upward momentum.
Possible scenarios:
1) Market stuck in a 250pt range, wait till supply/demand is
resolved
Then:
2) Breakout of upper boundary to test 13740
= long at support of upper boundary of range
3) Breakdown of lower boundary of range
= Short on rejection of 12950
Volume Analysis:
Weekly = Ave vol narrow spread up bar close off high
= Minor weakness
Daily: Higher vol narrow spread down bar close away from low
= minor demand
Price reaction levels:
Short on Test and Reject | Long on Test and Accept
14361 13740 13550 - 137440
12950 10710 - 11068
Remember to Like and Follow if you find this useful.
Have a profitable trading week ahead.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.